Explore 3 Stock Ideas & Industry Insights Download Free Report

Innovative Eyewear Inc.

Healthcare US LUCY

0.96USD
0.01(1.05%)

Last update at 2026-06-03T20:00:00Z

Day Range

0.951.00
LowHigh

52 Week Range

0.172.77
LowHigh

Fundamentals

  • Previous Close 0.95
  • Market Cap7.18M
  • Volume84480
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.81529M
  • Revenue TTM1.15M
  • Revenue Per Share TTM0.11
  • Gross Profit TTM 0.15M
  • Diluted EPS TTM-0.24

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -5.68183M -3.24451M -0.76818M -0.10943M
Minority interest - - - -
Net income -5.78700M -3.28394M -0.77527M -0.10943M
Selling general administrative 2.80M 1.39M 0.32M 0.04M
Selling and marketing expenses 2.06M 1.77M 0.15M 0.00292M
Gross profit -0.05629M 0.15M -0.01727M -0.00291M
Reconciled depreciation 0.03M 0.00768M 0.00099M 0.00000M
Ebit -5.57666M -3.20507M -0.65089M -0.26262M
Ebitda -5.54410M -3.19740M -0.64990M -0.10943M
Depreciation and amortization 0.03M 0.00768M 0.00099M -
Non operating income net other - - - -
Operating income -5.57666M -3.20507M -0.65089M -0.10943M
Other operating expenses 6.24M 3.90M 0.71M 0.11M
Interest expense 0.11M 0.04M 0.00497M 0.00000M
Tax provision - - - -
Interest income - - - -
Net interest income -0.10517M -0.03943M -0.00497M 0.00000M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.11M 0.04M 0.00709M -
Total revenue 0.66M 0.69M 0.06M 0.00482M
Total operating expenses 5.52M 3.35M 0.64M 0.11M
Cost of revenue 0.72M 0.54M 0.07M 0.00773M
Total other income expense net -0.10517M -0.03943M -0.11729M -
Discontinued operations - - - -
Net income from continuing ops -5.68183M -3.24451M -0.76818M -0.10943M
Net income applicable to common shares - -3.24451M -0.76818M -0.26262M
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 6.22M 4.69M 0.82M 0.21M 0.00000M
Intangible assets 0.40M 0.25M 0.16M 0.07M -
Earning assets - - - - -
Other current assets 0.38M 0.04M 0.00146M 0.11M -
Total liab 0.66M 0.67M 0.62M 0.77M 0.48M
Total stockholder equity 5.56M 4.02M 0.21M -0.55484M -0.48383M
Deferred long term liab - - - - -
Other current liab 0.04M 0.23M 0.16M 0.11M 0.48M
Common stock 0.00013M 0.00007M 0.00006M 0.00004M -
Capital stock 0.00013M 0.00007M 0.00006M 0.00004M 0.00000M
Retained earnings -16.96942M -10.30599M -4.62415M -1.37965M -0.61146M
Other liab - - - - -
Good will - - - - -
Other assets 0.00000M -0.00000M - - -
Cash 4.29M 3.59M 0.08M 0.03M 0.00000M
Cash and equivalents - - - - -
Total current liabilities 0.62M 0.60M 0.62M 0.77M 0.48M
Current deferred revenue 0.04M 0.03M - - -
Net debt -4.28745M -3.52975M 0.21M 0.57M -
Short term debt -0.04250M 0.06M 0.29M 0.60M -
Short long term debt - 0.06M 0.29M 0.60M -
Short long term debt total - 0.06M 0.29M 0.60M -
Other stockholder equity 22.53M 14.33M 4.83M 0.82M 0.13M
Property plant equipment - - 0.02M - -
Total current assets 5.62M 4.24M 0.64M 0.14M 0.00000M
Long term investments - - - - -
Net tangible assets - - 0.05M -0.62405M -0.48383M
Short term investments - - - - -
Net receivables 0.09M 0.11M 0.04M - -
Long term debt - - - - -
Inventory 0.86M 0.09M 0.28M 0.00404M 0.00000M
Accounts payable 0.58M 0.28M 0.17M 0.05M 0.00000M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.07M 0.08M - - -
Deferred long term asset charges - - - - -
Non current assets total 0.60M 0.45M 0.18M 0.07M 0.00000M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -0.21995M -0.11845M -0.05904M 0.00000M
Change to liabilities - 0.16M 0.05M 0.00000M
Total cashflows from investing activities - -0.11845M -0.05904M -0.05904M
Net borrowings - 1.00M 1.00M 1.00M
Total cash from financing activities 6.96M 1.39M 0.13M 0.13M
Change to operating activities - -0.04484M -0.02500M -0.02500M
Net income -5.68183M -3.24451M -0.76818M -0.10943M
Change in cash 3.51M 0.05M 0.03M 0.03M
Begin period cash flow 0.08M 0.03M 0.00000M 0.00000M
End period cash flow 3.59M 0.08M 0.03M 0.00000M
Total cash from operating activities -3.22442M -1.21416M -0.04026M -0.04026M
Issuance of capital stock 6.13M 0.49M 0.13M 0.00000M
Depreciation 0.03M 0.00768M 0.00099M 0.00099M
Other cashflows from investing activities - - - -
Dividends paid - - - -
Change to inventory 0.05M -0.25044M -0.02967M -0.02967M
Change to account receivables -0.18309M -0.04339M -0.04339M -0.04339M
Sale purchase of stock - - - -
Other cashflows from financing activities 1.48M 0.89M -0.05904M -0.11115M
Change to netincome - 2.20M 0.74M 0.26M
Capital expenditures 0.22M 0.12M 0.06M 0.02M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital -0.23078M -0.18113M -0.00822M 0.00000M
Stock based compensation 1.47M 1.33M 0.08M 0.00000M
Other non cash items 1.18M 0.87M 0.54M 0.11M
Free cash flow -3.44437M -1.33261M -0.09930M 0.00000M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LUCY
Innovative Eyewear Inc.
0.01 1.05% 0.96 - - 3.08 0.64 0.01 -0.0023
ISRG
Intuitive Surgical Inc
4.99 1.24% 407.29 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme
- -% 196.12 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA
-0.98 0.99% 98.17 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company
1.18 0.82% 145.61 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

Profile

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform various smartphone tasks hands-free. It also offers smart eyewear under the Lyte XL brand; and Nautica Powered by Lucyd smart eyewear collection and various branded accessories, including a power brick, cleaning cloth, and a slipcase adorned. In addition, the company provides Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with an individual's voice; and Lucyd app for iOS and Android to provide voice access to ChatGPT in Lucyd eyewear. It sells its products through various e-commerce and retail channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida.

Innovative Eyewear Inc.

11900 Biscayne Boulevard, North Miami, FL, United States, 33181

Key Executives

Name Title Year Born
Mr. Harrison Reed Gross Co-Founder, CEO & Director 1993
Mr. Konrad Dabrowski Co-Founder & CFO 1983
Mr. David Eric Cohen Co-Founder & CTO 1973
Mr. Jaoquin Abondano Chief Operating Officer 1984
Mr. Ekene Ofodile Senior VP Sales & Marketing NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.